Post Traumatic Stress Disorder (PTSD)
42
16
17
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
1 terminated out of 42 trials
93.8%
+7.2% vs benchmark
0%
0 trials in Phase 3/4
7%
1 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (42)
TMS for PTSD in Youth
Nurse-Led PTSD Treatment in Primary Care
Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)
Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery
Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD
Targeted Accelerated TMS for Post-Traumatic Stress Disorder
Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)
Treatment for Psychogenic Nonepileptic Seizures and Post-traumatic Stress Disorder Using Prolonged Exposure Therapy (PE) or Psychoeducation for PNES
Building Ukraine's Strength in PTSD Treatment and Research
Psychosocial Factors and Efficacy of Remote Cognitive Remediation for Post-Traumatic Stress Disorder
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
Mind-body Skills Groups for War-Related Trauma in Adolescents in Gaza
Inhaled Cannabis for Treatment of PTSD
Developing Innovative PTSD Treatment for Children
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain
Type I Hybrid Effectiveness-Implementation Trial of Primary Care Brief Mindfulness Training for Veterans
The Effectiveness of Guided Imagery on PCL-5 Scores in Adult Women With Post-Traumatic Stress Disorder
Suvorexant for Treatment of AUD and PTSD